PD-1 (clone Nivolumab) (clone ), anti-human antibody
€445.00
In stock
SKU
AC-ABV12038-100
Catalog Number: AC-ABV12038-100
Size: 100 µg
Host: Human IgG
Applications: E
Datasheet
Request Information
Size: 100 µg
Host: Human IgG
Applications: E
Datasheet
Request Information
Background:
Nivolumab, trade name Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.
Other Names:
Opdivo, PD-1
Primary Accession: Q02242
Gene Name: Pdcd1 {ECO:0000312|MGI:MGI:104879}
Gene ID: 18566
Nivolumab, trade name Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.
Other Names:
Opdivo, PD-1
Primary Accession: Q02242
Gene Name: Pdcd1 {ECO:0000312|MGI:MGI:104879}
Gene ID: 18566
| Is Featured? | No |
|---|
Write Your Own Review